Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.
暂无分享,去创建一个
Rajeev Kumar | Virendra Kumar | A. Hemal | N. Jagannathan | Rajeev Kumar | N. Gupta | Virendra Kumar | Ashok K Hemal | Rishi Nayyar | Narmada P Gupta | S Thulkar | N R Jagannathan | S Dattagupta | S. Thulkar | S. Dattagupta | R. Nayyar | N. R. Jagannathan
[1] W. Lowrance,et al. Emotional and cognitive burden of prostate cancer. , 2003, The Urologic clinics of North America.
[2] G. Durkan,et al. Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy? , 1999, BJU international.
[3] M. Stampfer,et al. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. , 1995, JAMA.
[4] T. Theorell,et al. Psychological reactions in men screened for prostate cancer. , 1995, British journal of urology.
[5] E. Crawford,et al. Screening for prostate cancer: current recommendations. , 2004, The Urologic clinics of North America.
[6] E. van Marck,et al. Inflammation in Prostate Biopsies of Men without Prostatic Malignancy or Clinical Prostatitis , 2000, European Urology.
[7] A. Hemal,et al. Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate , 2004, Urological Research.
[8] W. Catalona,et al. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. , 1994, The Journal of urology.
[9] J Kurhanewicz,et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.
[10] P. Carroll,et al. Proton HR‐MAS spectroscopy and quantitative pathologic analysis of MRI/3D‐MRSI‐targeted postsurgical prostate tissues , 2003, Magnetic resonance in medicine.
[11] J Kurhanewicz,et al. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. , 2003, Cancer investigation.
[12] P. Humphrey,et al. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study. , 1998, Urology.
[13] J. Hugosson,et al. Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. , 2003, European urology.
[14] Juni Palmgren,et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. , 2002, The New England journal of medicine.
[15] Brian R Matlaga,et al. Prostate biopsy: indications and technique. , 2003, The Journal of urology.
[16] A. Hemal,et al. Transrectal ultrasound‐guided biopsy of prostate voxels identified as suspicious of malignancy on three‐dimensional 1H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4–10 ng/ml , 2007, NMR in biomedicine.
[17] Hideaki Miyake,et al. Predictors of prostate cancer on repeat transrectal ultrasound‐guided systematic prostate biopsy , 2003, International journal of urology : official journal of the Japanese Urological Association.
[18] Taylor Murray,et al. Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.
[19] K. Kamoi,et al. Correlation of histological inflammation in needle biopsy specimens with serum prostate- specific antigen levels in men with negative biopsy for prostate cancer. , 2000, Urology.
[20] E. Feuer,et al. Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. , 1999, Journal of the National Cancer Institute.
[21] P. Carroll,et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.
[22] J. Kurhanewicz,et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. , 2005, Radiology.
[23] G N Collins,et al. Multiple transrectal ultrasound-guided prostatic biopsies--true morbidity and patient acceptance. , 1993, British journal of urology.
[24] W S Ng,et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. , 2004, The Journal of urology.
[25] J. Melamed,et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. , 1998, The Journal of urology.